Multicenter Case-Control Study
Also known as: multisite case-control study, collaborative case-control study, pooled case-control study, multi-institutional case-control study
A multicenter case-control study is an observational design that identifies individuals who have developed a disease (cases) and disease-free comparators (controls) across two or more study sites simultaneously. By pooling recruitment across hospitals, clinics, or geographic regions, the design achieves larger sample sizes, captures exposure variability over broader populations, and improves the statistical power needed to detect modest odds ratios for rare or heterogeneous diseases.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use a multicenter case-control study when the outcome is rare, requiring more cases than any single site can provide within a reasonable timeframe; when the research question demands generalisability beyond a local population; or when exposure prevalence varies geographically and the study aims to capture that variation. It is particularly well suited to studying determinants of rare cancers, uncommon adverse drug reactions, and diseases concentrated in specialist referral centers. Do not use this design when uniform case definitions cannot be applied across sites, when resources for coordination are insufficient to standardise data collection, or when the outcome is common enough that a single-center study provides adequate power — in that scenario the added complexity of multicenter coordination is not justified. Avoid this design if site-level exposure data are the primary interest; an ecological or multilevel design would be more appropriate.
Strengths & limitations
- Substantially increases sample size for rare diseases by pooling recruitment, enabling detection of modest effect sizes that single-center studies would miss.
- Broader geographic and demographic diversity improves external validity and allows assessment of whether associations generalise across different populations.
- Heterogeneity testing across centers provides a built-in replication check: consistent findings across multiple independent sites are stronger evidence than a single-site result.
- Efficient use of existing clinical infrastructure — recruitment can proceed simultaneously at all sites rather than sequentially.
- Facilitates the study of exposures with regional variability (e.g., dietary patterns, environmental pollutants, healthcare practices).
- Coordination costs are high: harmonising protocols, training staff, calibrating instruments, and managing data from multiple sites requires substantial funding and organisational effort.
- Differential ascertainment — cases and controls may be identified and recruited by different processes across sites, introducing systematic differences that confound associations.
- Residual center effects: even with careful standardisation, unmeasured site-level factors (referral patterns, hospital type, local disease definitions) can create heterogeneity that is difficult to fully adjust for.
- Recall and information bias affect all case-control designs; the multicenter structure does not eliminate these and may amplify them if data collectors are not uniformly trained.
- Combining data from sites with different source populations may violate the assumption that cases and controls are drawn from the same risk set.
Frequently asked
How is a multicenter case-control study different from a meta-analysis of case-control studies?
A multicenter case-control study collects primary data prospectively from all sites under a single shared protocol with harmonised exposure measurement and a common case definition. A meta-analysis synthesises data from previously published, independently conducted studies that may have used different designs, exposure definitions, and analytical approaches. The multicenter design therefore achieves greater internal consistency and avoids the heterogeneity problems that plague meta-analyses, but it requires upfront coordination among sites.
Must case and control ratios be identical at every center?
No. Center-specific recruitment constraints often mean that the case-to-control ratio varies by site. Provided center is adequately controlled in the analysis — via stratification, covariate adjustment, or conditional logistic regression — variation in the ratio across sites does not invalidate the pooled estimate. However, very unbalanced ratios (e.g., 1:10 at one site, 1:1 at another) should be reported and explored as a potential source of heterogeneity.
How do I handle exposures measured differently at different sites?
Before analysis, conduct a harmonisation exercise: map each site's exposure variable to a common coding scheme, assess comparability, and where necessary create a reduced categorical variable that all sites can support. For continuous exposures, a calibration sub-study using a common reference instrument at each site allows correction for systematic between-site differences. Sensitivity analyses restricting the sample to sites with the most comparable measurements help assess the impact of residual discordance.
When should center heterogeneity lead me to report site-specific rather than pooled results?
If the test for heterogeneity of odds ratios across centers yields a p-value below 0.10 or I-squared exceeds 50%, report both pooled and site-specific estimates. Substantial heterogeneity warrants investigation of potential moderators — for example, whether sites differ in case severity, exposure prevalence, or control source — before interpreting the pooled estimate as the primary finding.
Does a multicenter design eliminate selection bias?
No. Multicenter recruitment can reduce the impact of referral bias specific to a single institution, but it does not eliminate selection bias. Each site's controls must still be drawn from the same source population as that site's cases. If any site uses hospital controls while cases are population-based, or vice versa, differential selection bias remains and may affect the pooled estimate.
Sources
- Breslow, N. E., & Day, N. E. (1980). Statistical Methods in Cancer Research. Volume I: The Analysis of Case-Control Studies. IARC Scientific Publications No. 32. International Agency for Research on Cancer, Lyon. ISBN: 978-9283211327
- Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins, Philadelphia. ISBN: 978-0781755641
How to cite this page
ScholarGate. (2026, June 3). Multicenter Case-Control Study. ScholarGate. https://scholargate.app/en/epidemiology/multicenter-case-control-study
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Case-control studyEpidemiology↔ compare
- Matched case-control studyEpidemiology↔ compare
- Meta-analytic case-control studyEpidemiology↔ compare
- Multicenter cohort studyEpidemiology↔ compare
- Multicenter Randomized Clinical TrialEpidemiology↔ compare
- Nested case-controlEpidemiology↔ compare